allogeneic tumour cell vaccines. This study examines the effect of g-irradiation on a range of tumor cell lines in conjunction with suicide gene therapy of cancer. To determine
many new and novel tumor associated epitopes and neoantigens can potentially result in potent cancer vaccines. However, no verdict of immunogenicity may be made without a rapid method to measure ... biological activity…
this study was to monitor cell-based immune response developed by micro particulate ovarian cancer vaccine when administered via dissolving micro needles for transdermal routes in murine models and correlate ... propose…
test the immunogenecity and efficacy of orally delivered microparticle based therapeutic adjuvanted breast cancer vaccines. CpG and cyclophosphamide were used as adjuvant and T-reg inhibitor respectively in order…
Adaptive immunotherapy or vaccines has been tried as a therapeutic option against cancer in the past decade. It is necessary for patients ... advanced stage malignancy to have an efficient treatment. By taking in…
currently in the clinical practice. Our approach consists in an active immunotherapy, a cancer vaccine devoted to create an immune response as specific antibodies against the EGF. The proposed mechanism ... feasibility…
Breast cancer patients were vaccinated in the adjuvant setting with an autologous, allogeneic whole cell vaccine to evaluate the effect on host lymphocyte immunity and disease free survival. We began ... preparing whole…
care in some patients. Here we propose the development of an in situ autologous cancer vaccine, inCVAX, for the treatment of hepatocellular cancer (HCC). inCVAX is based on the induction
trial in prostate and renal cancer patients with GX301, a new generation cancer vaccine. This multi-peptidic vaccine includes four telomerase peptides, which bind promiscuously several HLA class ... associated with…
renal cell carcinoma and four breast cancer patients were treated twice with autologous CD34+ hematopoietic stem cell- derived, GM-CSF/IFN-γ-differentiated DCs and low-dose (200MIU ... week interval in a phase Ð?/II…
Cancer vaccines are a rapidly evolving field, focusing on preventing virus-linked malignancies like those caused by HPV and HBV. Advances include therapeutic vaccines targeting existing cancers and novel platforms…